A detailed history of Pro Share Advisors LLC transactions in Amgen Inc stock. As of the latest transaction made, Pro Share Advisors LLC holds 690,993 shares of AMGN stock, worth $183 Million. This represents 0.56% of its overall portfolio holdings.

Number of Shares
690,993
Previous 661,578 4.45%
Holding current value
$183 Million
Previous $207 Million 7.71%
% of portfolio
0.56%
Previous 0.57%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$309.38 - $337.38 $9.1 Million - $9.92 Million
29,415 Added 4.45%
690,993 $223 Million
Q2 2024

Aug 13, 2024

SELL
$262.75 - $319.31 $13.2 Million - $16 Million
-50,105 Reduced 7.04%
661,578 $207 Million
Q1 2024

May 08, 2024

BUY
$268.87 - $324.56 $18.7 Million - $22.6 Million
69,693 Added 10.86%
711,683 $202 Million
Q4 2023

Feb 14, 2024

SELL
$255.7 - $288.46 $23.3 Million - $26.3 Million
-91,019 Reduced 12.42%
641,990 $185 Million
Q3 2023

Nov 13, 2023

BUY
$218.65 - $271.46 $12.4 Million - $15.4 Million
56,700 Added 8.38%
733,009 $197 Million
Q2 2023

Aug 10, 2023

SELL
$214.27 - $253.37 $8.56 Million - $10.1 Million
-39,972 Reduced 5.58%
676,309 $150 Million
Q1 2023

May 11, 2023

BUY
$225.79 - $275.2 $10.5 Million - $12.8 Million
46,476 Added 6.94%
716,281 $173 Million
Q4 2022

Feb 02, 2023

SELL
$229.03 - $291.01 $8.3 Million - $10.5 Million
-36,241 Reduced 5.13%
669,805 $176 Million
Q3 2022

Nov 04, 2022

SELL
$224.46 - $253.15 $24.9 Million - $28.1 Million
-110,872 Reduced 13.57%
706,046 $159 Million
Q2 2022

Aug 01, 2022

SELL
$230.71 - $256.74 $103 Million - $114 Million
-444,404 Reduced 35.23%
816,918 $199 Million
Q1 2022

May 10, 2022

SELL
$219.27 - $242.57 $21.4 Million - $23.7 Million
-97,567 Reduced 7.18%
1,261,322 $305 Million
Q4 2021

Feb 08, 2022

BUY
$198.88 - $227.6 $77.4 Million - $88.6 Million
389,327 Added 40.15%
1,358,889 $306 Million
Q3 2021

Nov 12, 2021

BUY
$212.27 - $248.7 $12.9 Million - $15.1 Million
60,805 Added 6.69%
969,562 $206 Million
Q2 2021

Aug 13, 2021

SELL
$233.58 - $259.14 $2.84 Million - $3.15 Million
-12,138 Reduced 1.32%
908,757 $222 Million
Q1 2021

May 14, 2021

BUY
$221.91 - $258.6 $31.3 Million - $36.5 Million
141,186 Added 18.11%
920,895 $229 Million
Q4 2020

Feb 09, 2021

BUY
$216.38 - $257.67 $17.9 Million - $21.3 Million
82,516 Added 11.84%
779,709 $179 Million
Q3 2020

Nov 13, 2020

BUY
$234.65 - $260.95 $55.1 Million - $61.3 Million
234,897 Added 50.81%
697,193 $177 Million
Q2 2020

Aug 03, 2020

BUY
$197.81 - $242.74 $12.9 Million - $15.8 Million
65,217 Added 16.42%
462,296 $109 Million
Q1 2020

May 15, 2020

SELL
$182.24 - $241.7 $30 Million - $39.8 Million
-164,507 Reduced 29.29%
397,079 $80.5 Million
Q4 2019

Feb 12, 2020

BUY
$189.21 - $243.2 $9.43 Million - $12.1 Million
49,828 Added 9.74%
561,586 $135 Million
Q3 2019

Nov 12, 2019

SELL
$174.11 - $208.62 $2.85 Million - $3.41 Million
-16,346 Reduced 3.1%
511,758 $99 Million
Q2 2019

Aug 13, 2019

SELL
$166.7 - $195.41 $11.5 Million - $13.5 Million
-69,242 Reduced 11.59%
528,104 $97.3 Million
Q1 2019

May 15, 2019

BUY
$180.87 - $203.88 $1.81 Million - $2.04 Million
9,999 Added 1.7%
597,346 $113 Million
Q4 2018

Feb 14, 2019

BUY
$178.4 - $208.25 $12.6 Million - $14.7 Million
70,353 Added 13.61%
587,347 $114 Million
Q3 2018

Nov 14, 2018

SELL
$185.29 - $208.89 $10.4 Million - $11.7 Million
-56,078 Reduced 9.79%
516,994 $107 Million
Q2 2018

Aug 13, 2018

SELL
$166.05 - $186.51 $14.4 Million - $16.1 Million
-86,424 Reduced 13.1%
573,072 $106 Million
Q1 2018

May 14, 2018

BUY
$169.43 - $198.0 $5.71 Million - $6.67 Million
33,691 Added 5.38%
659,496 $112 Million
Q4 2017

Feb 14, 2018

BUY
$168.79 - $188.59 $20.5 Million - $23 Million
121,716 Added 24.15%
625,805 $109 Million
Q3 2017

Nov 13, 2017

BUY
$167.29 - $191.0 $7.66 Million - $8.74 Million
45,762 Added 9.98%
504,089 $94 Million
Q2 2017

Aug 11, 2017

BUY
N/A
458,327
458,327 $78.9 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.